Top Story

American Indians, Alaskan Natives experienced shorter cancer survival, even with equal access to care

November 21, 2014

Cancer survivors of American Indian or Alaskan Native descent demonstrated poorer rates of 5- and 10-year cancer survival than non-Hispanic whites even when they had equal access to health care, according to study results presented at the American Association for Cancer Research Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved in San Antonio.

Marc A. Emerson, MPH, cancer research training award fellow in the division of cancer control and population sciences at the NCI, and colleagues used Kaiser Permanente Northern California electronic health records to collect data on 1,022 American Indians and Alaskan Natives diagnosed with primary invasive cancer between 1997 and 2012.

Jeffrey Kullgren, MD In the Journals

Lottery incentive improved fecal occult blood test completion rates

November 21, 2014
Among several different financial incentives tested, a lottery-style cash reward increased rates of completion of fecal occult blood tests for colon cancer screening…
Meeting News Coverage

Preoperative transcutaneous oximetry predicted complications in sarcoma radiation

November 21, 2014
The use of preoperative transcutaneous oximetry may be useful in predicting wound-healing complications in patients undergoing surgery for soft tissue sarcomas after…
Meeting News Coverage

HPV vaccination rates among girls lowest in states with highest cervical cancer rates

November 20, 2014
The percentage of girls who receive HPV vaccinations is considerably lower in states that have higher rates of cervical cancer incidence and mortality, according to…

NIH renews research grants on aging

November 20, 2014
The NIH has announced renewed funding of $23.4 million for 11 Edward R. Roybal Centers for Research on Applied Gerontology and the designation of two additional…
More News Headlines »
Activity cover

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
Meeting News Coverage Video
thumbnail for video 3886443649001

Risk stratification guidelines help determine treatment for thyroid cancer

November 11, 2014
Fabian Pitoia, MD,  head of the thyroid section of the division of endocrinology at the Hospital de Clinicas of…
More »
Low Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS: Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »